MacroGenics | Resultat Før Skatt



Pre Tax Profit Endring Dato
AbbVie USD 4.81B 1.54B 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Daiichi Sankyo JPY 82.41B 26M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Genmab DKK 3.6B 1.88B 2024-12
Geron USD -25352000 1.1M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
J&J USD 5.42B 1.86B 2024-12
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 5.22B 114M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Xencor USD -52626000 6.33M 2024-12



MacroGenics Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.